# Lingel Tech

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/lingel-tech

- Industry: Materials
- Headquarters: Shanghai, China
- Website: www.lingeltech.com
- Latest round: Series B (Feb 13, 2026)
- Investors on record: 2

## About

Based in Shanghai, China and founded in 2021, Shanghai Lingjiu Medical Technology Co., Ltd., trading as Lingel Tech, is a biomedical materials developer dedicated to building a comprehensive platform for the research, development, production, sales, and service of innovative bioengineering materials in the field of tissue repair and regenerative medicine. In February 2026, Lingel Tech closed Series B+ funding from new investors Shanghai Fengxian Traffic Industry and Fortera Capital.
The company specializes in the development and provision of advanced medical technology solutions aimed at enhancing patient care and optimizing healthcare processes. Its core product offerings revolve around innovative medical devices designed for diagnostics, treatment, and patient monitoring. 
Revenue generation for the company is structured around direct sales and partnerships within the healthcare sector. The company engages in B2B transactions by supplying its medical devices to healthcare institutions and establishing pricing through contractual agreements based on product volume.

## Funding rounds

- Series B, Feb 13, 2026 — Shanghai Fengxian Traffic Industry, Fortera Capital

## Investors

- Shanghai Fengxian Traffic Industry — Series B
- Fortera Capital (https://capitalatlas.ai/funds/fortera-capital) — Series B